Inmune Bio, Inc. INMB
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-02-04
Inmune Bio, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 812,895 | $7.2M |
| AQR CAPITAL MANAGEMENT LLC | 270,317 | $305,458 |
| RENAISSANCE TECHNOLOGIES LLC | 17,000 | $19,210 |
| CITADEL ADVISORS LLC | 12,500 | $14,125 |
Source: SEC EDGAR filings · CIK 0001711754 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.